Inspire Medical Systems (INSP) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
INSP dips 1.9% to $68.79. Closed at $68.79, -1.90% vs the prior close of $70.12. Day range $68.54–$71.25, opened at $70.40.
INSP daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — INSP dips 1.9% to $68.79
- Closed at $68.79, -1.90% vs the prior close of $70.12. Day range $68.54–$71.25, opened at $70.40.
- Volume was 414.14K shares, 0.5x its 50-day average of 758.82K — lighter than usual.
- Price is +3.9% vs its 50-day average ($66.22) and +15.1% vs its 200-day average ($59.79).
- 52-week range $38.91–$147.03; today's close sits at 28% of that range, 53.2% below the 52-week high.
Oct 15, 2026 — INSP jumps 3.0% to $70.12
- Closed at $70.12, +3.01% vs the prior close of $68.07. Day range $68.33–$70.40, opened at $68.72.
- Volume was 621.20K shares, 0.8x its 50-day average of 775.36K.
- Price is +6.2% vs its 50-day average ($66.02) and +17.1% vs its 200-day average ($59.90).
- 52-week range $38.91–$147.03; today's close sits at 29% of that range, 52.3% below the 52-week high.
Oct 14, 2026 — INSP dips 1.1% to $68.07
- Closed at $68.07, -1.15% vs the prior close of $68.86. Day range $67.41–$69.57, opened at $69.33.
- Volume was 855.10K shares, 1.1x its 50-day average of 804.83K.
- Price is +3.4% vs its 50-day average ($65.82) and +13.4% vs its 200-day average ($60.02).
- 52-week range $38.91–$147.03; today's close sits at 27% of that range, 53.7% below the 52-week high.
Oct 13, 2026 — INSP slides 3.7% to $68.86
- Closed at $68.86, -3.68% vs the prior close of $71.49. Day range $68.62–$72.46, opened at $71.37.
- Volume was 1.04M shares, 1.3x its 50-day average of 803.87K.
- Price is +4.7% vs its 50-day average ($65.74) and +14.5% vs its 200-day average ($60.16).
- 52-week range $38.91–$147.03; today's close sits at 28% of that range, 53.2% below the 52-week high.
Oct 12, 2026 — INSP jumps 3.8% to $71.49
- Closed at $71.49, +3.77% vs the prior close of $68.89. Day range $69.41–$72.01, opened at $69.99.
- Volume was 1.01M shares, 1.3x its 50-day average of 797.08K.
- Price is +9.3% vs its 50-day average ($65.41) and +18.6% vs its 200-day average ($60.29).
- 52-week range $38.91–$147.03; today's close sits at 30% of that range, 51.4% below the 52-week high.
Oct 9, 2026 — INSP jumps 3.3% to $68.89
- Closed at $68.89, +3.30% vs the prior close of $66.69. Day range $66.83–$69.73, opened at $67.20.
- Volume was 867.30K shares, 1.1x its 50-day average of 793.26K.
- Price is +6.0% vs its 50-day average ($64.98) and +14.0% vs its 200-day average ($60.41).
- 52-week range $38.91–$147.03; today's close sits at 28% of that range, 53.1% below the 52-week high.
Oct 8, 2026 — INSP dips 1.1% to $66.69, 3 down days in a row
- Closed at $66.69, -1.13% vs the prior close of $67.45. Day range $66.07–$68.00, opened at $67.12.
- Volume was 846.70K shares, 1.1x its 50-day average of 797.43K.
- Price is +3.2% vs its 50-day average ($64.60) and +10.1% vs its 200-day average ($60.56).
- 52-week range $38.91–$147.03; today's close sits at 26% of that range, 54.6% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — INSP dips 1.1% to $67.45 on 1.9x normal volume
- Closed at $67.45, -1.10% vs the prior close of $68.20. Day range $66.50–$68.37, opened at $67.13.
- Volume was 1.48M shares, 1.9x its 50-day average of 786.44K — unusually heavy trading.
- Price is +4.9% vs its 50-day average ($64.29) and +11.1% vs its 200-day average ($60.71).
- 52-week range $38.91–$147.03; today's close sits at 26% of that range, 54.1% below the 52-week high.
Oct 6, 2026 — INSP slides 3.6% to $68.20
- Closed at $68.20, -3.60% vs the prior close of $70.75. Day range $67.99–$71.86, opened at $71.23.
- Volume was 869.50K shares, 1.1x its 50-day average of 787.95K.
- Price is +6.6% vs its 50-day average ($63.98) and +12.1% vs its 200-day average ($60.84).
- 52-week range $38.91–$147.03; today's close sits at 27% of that range, 53.6% below the 52-week high.
Oct 5, 2026 — INSP rises 1.1% to $70.75
- Closed at $70.75, +1.11% vs the prior close of $69.97. Day range $68.67–$71.36, opened at $69.66.
- Volume was 632.10K shares, 0.8x its 50-day average of 788.47K.
- Price is +11.2% vs its 50-day average ($63.64) and +15.8% vs its 200-day average ($61.09).
- 52-week range $38.91–$147.03; today's close sits at 29% of that range, 51.9% below the 52-week high.
Oct 2, 2026 — INSP dips 1.1% to $69.97
- Closed at $69.97, -1.14% vs the prior close of $70.78. Day range $68.44–$71.74, opened at $71.74.
- Volume was 761.90K shares, 1.0x its 50-day average of 787.43K.
- Price is +10.7% vs its 50-day average ($63.21) and +14.1% vs its 200-day average ($61.32).
- 52-week range $38.91–$147.03; today's close sits at 29% of that range, 52.4% below the 52-week high.
INSP latest news & SEC filings
Every SEC filing by or about INSP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Ellis Gary Lee received an award of 431 shares at $68.07 (≈$29.34K) on Oct 14, 2026; now holds 11,850
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Melenikiotou Georgia received an award of 255 shares at $68.07 (≈$17.36K) on Oct 14, 2026; now holds 8,584
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Carrel Michael H received an award of 203 shares at $68.07 (≈$13.82K) on Oct 14, 2026; now holds 5,834
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Broader Shelley G received an award of 284 shares at $68.07 (≈$19.33K) on Oct 14, 2026; now holds 9,138
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 24, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 3, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $200.58M (prior year $217.09M) (-7.6% vs Jun 30, 2025)
- Net income: $314.00K (prior year -$3.59M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.01 (prior year -$0.12) (swung to profit vs Jun 30, 2025)
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 28, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 2, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade INSP
- Last results release: Aug 3, 2026 (8-K Item 2.02). Previous ones: May 4, 2026, Feb 11, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 2, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.53% (largest 5.8%).
- Liquidity: about 892.59K shares (≈$61.40M) trade per day on average.
- 52-week position: $68.79 vs a range of $38.91–$147.03 (28% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Jason P Kelly sold 963 shares on Aug 7, 2026.
- Latest filings: 10-Q Aug 3, 2026; 8-K Aug 3, 2026; 8-K Jul 24, 2026.
- Share count: 28.91M shares outstanding (Jul 30, 2026), -2.2% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Surgical & Medical Instruments & Apparatus.
INSP market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 70.40 | 71.25 | 68.54 | 68.79 | 414.14K |
| Oct 15, 2026 | 68.72 | 70.40 | 68.33 | 70.12 | 621.20K |
| Oct 14, 2026 | 69.33 | 69.57 | 67.41 | 68.07 | 855.10K |
| Oct 13, 2026 | 71.37 | 72.46 | 68.62 | 68.86 | 1.04M |
| Oct 12, 2026 | 69.99 | 72.01 | 69.41 | 71.49 | 1.01M |
| Oct 9, 2026 | 67.20 | 69.73 | 66.83 | 68.89 | 867.30K |
| Oct 8, 2026 | 67.12 | 68.00 | 66.07 | 66.69 | 846.70K |
| Oct 7, 2026 | 67.13 | 68.37 | 66.50 | 67.45 | 1.48M |
| Oct 6, 2026 | 71.23 | 71.86 | 67.99 | 68.20 | 869.50K |
| Oct 5, 2026 | 69.66 | 71.36 | 68.67 | 70.75 | 632.10K |
| Oct 2, 2026 | 71.74 | 71.74 | 68.44 | 69.97 | 761.90K |
| Oct 1, 2026 | 70.50 | 75.31 | 68.98 | 70.78 | 2.02M |
| Sep 30, 2026 | 73.09 | 73.25 | 68.50 | 69.36 | 997.20K |
| Sep 29, 2026 | 69.78 | 73.24 | 69.18 | 73.18 | 873.50K |
| Sep 28, 2026 | 70.83 | 70.93 | 69.59 | 70.00 | 442.30K |
| Sep 25, 2026 | 68.65 | 70.98 | 68.13 | 70.50 | 609.80K |
| Sep 24, 2026 | 69.11 | 70.58 | 68.65 | 68.81 | 580.60K |
| Sep 23, 2026 | 71.38 | 72.10 | 68.15 | 69.06 | 729.60K |
| Sep 22, 2026 | 75.32 | 76.10 | 71.19 | 71.30 | 1.12M |
| Sep 21, 2026 | 76.50 | 77.26 | 74.92 | 75.72 | 1.08M |
About Inspire Medical Systems
Inspire Medical Systems (INSP) is listed on the NYSE and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in GOLDEN VALLEY, MN. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1609550.
INSP board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Shelley G Broader | Director | Jul 17, 2026 |
| Cynthia Burks | Director | May 4, 2026 |
| Michael H Carrel | Director | Jul 27, 2026 |
| Myriam Curet | Director | May 4, 2026 |
| Gary Lee Ellis | Director | Jul 17, 2026 |
| Timothy P. Herbert | CEO and President | Feb 24, 2026 |
| Dana G Jr. Mead | Director | May 4, 2026 |
| Georgia Melenikiotou | Director | Jul 17, 2026 |
| Casey M Tansey | Director | Jul 17, 2026 |
| Shawn Mccormick | Director | May 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Richard Buchholz | Interim CFO | Feb 18, 2026 |
| Timothy P. Herbert | CEO and President | Feb 24, 2026 |
| Jason P Kelly | See Remarks | Sep 2, 2026 |
| Melissa Mann | Chief People Officer | Aug 4, 2026 |
| Matthew J Osberg | Chief Financial Officer | Feb 24, 2026 |
| Bryan K Phillips | See Remarks | Feb 24, 2026 |
| John Rondoni | See Remarks | May 19, 2026 |
| Carlton Weatherby | See Remarks | Feb 24, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 7, 2026 | Jason P Kelly | Sale | 963 | $59.55 |
| Aug 7, 2026 | Jason P Kelly | Sale | 963 | $59.55 |
| Aug 7, 2026 | Jason P Kelly | Sale | 963 | $59.55 |
| Aug 7, 2026 | Jason P Kelly | Sale | 963 | $59.55 |
| May 15, 2026 | John Rondoni | Sale | 2,641 | $43.28 |
| May 15, 2026 | John Rondoni | Sale | 2,641 | $43.28 |
| May 15, 2026 | John Rondoni | Sale | 2,641 | $43.28 |
| May 15, 2026 | John Rondoni | Sale | 2,641 | $43.28 |
| May 14, 2026 | John Rondoni | Sale | 700 | $43.01 |
| May 14, 2026 | John Rondoni | Sale | 700 | $43.01 |
| May 14, 2026 | John Rondoni | Sale | 700 | $43.01 |
| May 14, 2026 | John Rondoni | Sale | 700 | $43.01 |
| May 8, 2026 | Shawn Mccormick | Sale | 696 | $45.31 |
| May 8, 2026 | Shawn Mccormick | Sale | 696 | $45.31 |
| May 8, 2026 | Shawn Mccormick | Sale | 696 | $45.31 |
INSP financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $911.98M | $145.42M | 4.89 | $116.98M |
| Dec 31, 2024 | $802.80M | $53.51M | 1.75 | $130.25M |
| Dec 31, 2023 | $624.80M | $-21.15M | -0.72 | $24.65M |
| Dec 31, 2022 | $407.86M | $-44.88M | -1.60 | $11.57M |
| Dec 31, 2021 | $233.39M | $-42.04M | -1.54 | $-20.12M |
Latest balance sheet: total assets $925.99M, total liabilities $100.41M, cash $127.76M (as of Jun 30, 2026).
INSP earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 3, 2026 | 8-K Item 2.02 (results) | $52.22 |
| May 4, 2026 | 8-K Item 2.02 (results) | $54.84 |
| Feb 11, 2026 | 8-K Item 2.02 (results) | $68.21 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $96.93 |
| Nov 3, 2025 | 8-K Item 2.02 (results) | $73.71 |
| Aug 4, 2025 | 8-K Item 2.02 (results) | $129.95 |
| May 5, 2025 | 8-K Item 2.02 (results) | $158.74 |
| Feb 10, 2025 | 8-K Item 2.02 (results) | $180.99 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $175.43 |
| Nov 4, 2024 | 8-K Item 2.02 (results) | $192.71 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| Jul 29, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on INSP
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.